USP9X and pancreatic ductal adenocarcinoma: These findings provide a molecular framework for the previous observation that USP9x is downregulated in pancreatic ductal adenocarcinoma (PDA) [20] and for the finding, presented here, that low levels of USP9x expression correlate with poor prognosis in renal clear cell carcinoma (ccRCC).